Sign In
Buy LOGC
$9.02
-0.300 (-3.22%)
At Close: Jun 22, 2026
ContextLogic Inc. Reports Second-Quarter Financial Results
04:15pm, Thursday, 08'th Aug 2024
OAKLAND, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter
Why Is LogicBio (LOGC) Stock Up 600% Today?
10:33am, Monday, 03'rd Oct 2022
Source: Roland Magnusson / Shutterstock.com LogicBio (NASDAQ: LOGC ) stock is seeing massive gains on Monday following news that AstraZeneca (NASDAQ: AZN ) subsidiary Alexion is acquiring the clinical
Why AstraZeneca (AZN) Is Buying LogicBio Therapeutics (LOGC) In About A $68 Million Deal
09:27am, Monday, 03'rd Oct 2022
LogicBio Therapeutics, Inc. (LOGC) announced it is being acquired in a deal valued at about $68 million. These are the details.
5 Big Winners as Dollar Strengthens on Fed Rate Hike
09:47am, Tuesday, 27'th Sep 2022
A stronger dollar is a boon for Consolidated Water (CWCO), Ashford Hospitality Trust (AHT), BankFinancial (BFIN), LogicBio Therapeutics (LOGC) and ProPhase Labs (PRPH) that have high domestic exposure
5 Winning Stocks Backed by the Overlooked Trick of Rising P/E
09:02am, Tuesday, 27'th Sep 2022
Want to try an out-of-the-box approach? Tap Eastside Distilling (EAST), LogicBio Therapeutics (LOGC), Seabridge Gold (SA), Suzano (SUZ) and J Douglas Emmett (DEI).
Why LogicBio Therapeutics Shares Are Popping Off Today
10:26am, Monday, 09'th May 2022
LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher by 63.48% at $0.81 after the company announced the FDA lifted the clinical hold on its LB-001 Investigational New Drug Application, a
Stock Market Crash: 4 Penny Stocks To Watch As Dow Slides
09:22am, Monday, 09'th May 2022
Penny stocks to watch as stock market crash continues. The post Stock Market Crash: 4 Penny Stocks To Watch As Dow Slides appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc
LogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric Trial
08:50am, Monday, 09'th May 2022
The FDA has lifted the clinical hold on LogicBio Therapeutics Inc's (NASDAQ: LOGC) LB-001 Investigational New Drug Application (IND) to resume patient enrollment in Phase 1/2 SUNRISE trial in pedi
LogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing Conference
04:30pm, Wednesday, 23'rd Mar 2022
LEXINGTON, Mass. , March 23, 2022 /PRNewswire/ -- LogicBio ® Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today announced that president and chief executive office
Why Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today?
12:34pm, Wednesday, 02'nd Feb 2022
The FDA has placed a clinical hold on LogicBio Therapeutics Inc's (NASDAQ: LOGC) Phase 1/2 SUNRISE trial of LB-001 in pediatric patients with methylmalonic acidemia (MMA). The hold follows after t
LogicBio Therapeutics (LOGC): Why The Price Substantially Fell Today
10:42am, Wednesday, 02'nd Feb 2022
The stock price LogicBio Therapeutics Inc (NASDAQ: LOGC) fell by over 50% during intraday trading today. This is why it happened.
LogicBio Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
04:05pm, Friday, 24'th Sep 2021
LEXINGTON, Mass., Sept. 24, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene editing and gene delivery platforms to address r
LogicBio Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08:00am, Friday, 10'th Sep 2021
LEXINGTON, Mass., Sept. 10, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene editing and gene delivery platforms to address r
LogicBio Therapeutics (LOGC) Reports Q2 Loss, Lags Revenue Estimates
10:50am, Monday, 09'th Aug 2021
LogicBio Therapeutics (LOGC) delivered earnings and revenue surprises of -32.00% and -83.99%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
LogicBio Therapeutics to Participate in William Blair Biotech Focus Conference 2021
07:00am, Thursday, 08'th Jul 2021
LEXINGTON, Mass., July 8, 2021 /PRNewswire/ -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene editing and gene delivery platforms to address rar
